Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Inmune Bio, Inc. has filed 591 SEC EDGAR filings since 13 Jul 2017

SEC filing history

Showing 326-350 of 591 matching filings.

Per page
25
Current page
14
SC 13G File 005-90859

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
19 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
15 Jul 2021
Reporting date
13 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254221

PROSPECTUS SUPPLEMENT

Filing date
15 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
15 Jul 2021
Reporting date
12 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Jul 2021
Reporting date
13 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jul 2021
Reporting date
09 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jul 2021
Reporting date
07 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jul 2021
Reporting date
07 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jul 2021
Reporting date
07 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38793

AMENDMENT NO. 1 TO FORM 8-K

Filing date
01 Jul 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
24 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2021
Reporting date
14 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
15 Jun 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Jun 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Jun 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
03 Jun 2021
Reporting date
02 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
03 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
07 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .